Exact Sciences
EXAS
#1782
Rank
NZ$15.66 B
Marketcap
$84.63
Share price
-2.28%
Change (1 day)
-15.84%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Exact Sciences (EXAS) - Total assets

Total assets on the balance sheet as of September 2024 : NZ$11.38 Billion

According to Exact Sciences's latest financial reports the company's total assets are NZ$11.38 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Exact Sciences - Total assets on balance sheet (from 2001 to 2024)

Total assets by year

Year Total assets Change
2023-12-31NZ$10.23 B4.34%
2022-12-31NZ$9.80 B0.21%
2021-12-31NZ$9.78 B43.38%
2020-12-31NZ$6.82 B31.13%
2019-12-31NZ$5.20 B129.11%
2018-12-31NZ$2.27 B169.58%
2017-12-31NZ$0.84 B54.84%
2016-12-31NZ$0.54 B2.34%
2015-12-31NZ$0.53 B33.22%
2014-12-31NZ$0.39 B123.76%
2013-12-31NZ$0.17 B30.92%
2012-12-31NZ$0.13 B9.71%
2011-12-31NZ$0.12 B-0.7%
2010-12-31NZ$0.12 B252.6%
2009-12-31NZ$35.48 M249.1%
2008-12-31NZ$10.16 M-46.66%
2007-12-31NZ$19.05 M-43.76%
2006-12-31NZ$33.87 M-38.81%
2005-12-31NZ$55.36 M-29.59%
2004-12-31NZ$78.63 M47.39%
2003-12-31NZ$53.35 M-44.25%
2002-12-31NZ$95.7 M-37.02%
2001-12-31NZ$0.15 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
NZ$1.83 B-83.92%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$2.15 B-81.11%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$37.29 M-99.67%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$234.68 B 1,961.10%๐Ÿ‡ซ๐Ÿ‡ท France